[go: up one dir, main page]

JP2003310744A - Medical covering members - Google Patents

Medical covering members

Info

Publication number
JP2003310744A
JP2003310744A JP2002122237A JP2002122237A JP2003310744A JP 2003310744 A JP2003310744 A JP 2003310744A JP 2002122237 A JP2002122237 A JP 2002122237A JP 2002122237 A JP2002122237 A JP 2002122237A JP 2003310744 A JP2003310744 A JP 2003310744A
Authority
JP
Japan
Prior art keywords
medical
fluorine
adhesion
film
diamond
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2002122237A
Other languages
Japanese (ja)
Other versions
JP3714471B2 (en
Inventor
Tetsuya Suzuki
哲也 鈴木
Atsushi Shimada
厚 島田
Manabu Sato
学 佐藤
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Keio University
Original Assignee
Keio University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Keio University filed Critical Keio University
Priority to JP2002122237A priority Critical patent/JP3714471B2/en
Publication of JP2003310744A publication Critical patent/JP2003310744A/en
Application granted granted Critical
Publication of JP3714471B2 publication Critical patent/JP3714471B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Crystals, And After-Treatments Of Crystals (AREA)
  • Chemical Vapour Deposition (AREA)
  • Electrotherapy Devices (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Materials For Medical Uses (AREA)
  • Surgical Instruments (AREA)
  • Media Introduction/Drainage Providing Device (AREA)

Abstract

(57)【要約】 【課 題】 医療用部材への強固な密着性及び高い耐
摩耗性を持ち、血液や筋肉、血管などの人体組織に対し
ての耐付着性が十分なDLC被膜を表面に形成した医療
用DLC被覆部材の提供。 【解決手段】 SP2結合とSP3結合を有し、かつ、
DLC被膜と部材の界面から0.1μm以内において、
ダイヤモンド様炭素膜のSP2/SP3比が、1〜10
であり、かつDLC被膜表面から深さ0.1ミクロン以
内においてフッ素濃度が10〜40体積%範囲内で連続
又は不連続のフッ素の濃度勾配を有するDLC被膜を形
成した医療用部材。
(57) [Summary] [Problem] A DLC film that has strong adhesion to medical materials and high abrasion resistance and has sufficient adhesion resistance to human tissues such as blood, muscle, blood vessels, etc. Provided is a medical DLC covering member formed on a substrate. SOLUTION: It has SP2 bond and SP3 bond, and
Within 0.1 μm from the interface between the DLC coating and the member,
The SP2 / SP3 ratio of the diamond-like carbon film is 1 to 10
And a medical member having a DLC coating having a continuous or discontinuous fluorine concentration gradient in a range of 10 to 40% by volume of fluorine at a depth of 0.1 μm or less from the surface of the DLC coating.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【発明の属する技術分野】本発明は、耐付着性や耐擬着
性を有し、さらに基材のへ強固な密着性及び高い耐摩耗
性を併せ持つ医療用部材に関する。また、本発明は、カ
テーテル、ガイドワイヤー、ステント、ペースメーカー
リードなどの体内留置用器材や注射針、メス、(傷口保
持部品)などの人体組識,血液等と直接的に接触する各
種医療用部材に関する。
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a medical member having adhesion resistance and pseudo-adhesion resistance, as well as strong adhesion to a base material and high abrasion resistance. Further, the present invention provides various medical members that directly contact with indwelling devices such as catheters, guide wires, stents, and pacemaker leads, human needles such as injection needles, scalpels, (wound holding parts), and blood. Regarding

【0002】[0002]

【従来の技術】従来は、医療機器にDLCを被覆し、被
膜全体に弗素を含有することが開示されており、以下に
記載する発明が知られている。例えば、特開平11−3
13884号公報には、ステント基材と、ステント基材
の少なくとも表面の一部に注入された炭素イオン注入層
と、該炭素イオン注入層の上に成膜されたダイヤモンド
ライクカーボン膜とを具備したことを特徴とする生体留
置用ステントさらにダイヤモンドライクカーボン膜が積
層されている生体留置用ステントが、特開2001−2
9447公報には、医療器本体の表面の少なくとも一部
を、原子比(F/F+C+H)が60%以上であるフッ
素含有ダイヤモンドライクカーボン膜で被覆したことを
特徴とする体内埋込み医療器が、特開2001−238
962号公報には芯線体とその表面に形成されたDLC
被膜とを有することを特徴とする医療用挿通線体がそれ
ぞれ開示されている。
2. Description of the Related Art Conventionally, it has been disclosed that a medical device is coated with DLC and that the entire coating contains fluorine, and the inventions described below are known. For example, JP-A-11-3
Japanese Patent No. 13884 includes a stent base material, a carbon ion-implanted layer injected into at least a part of the surface of the stent base material, and a diamond-like carbon film formed on the carbon ion-implanted layer. A stent for living body in which a stent for living body is further laminated with a diamond-like carbon film is disclosed in Japanese Patent Application Laid-Open No. 2001-2.
9447 discloses an implantable medical device characterized in that at least a part of the surface of the medical device main body is coated with a fluorine-containing diamond-like carbon film having an atomic ratio (F / F + C + H) of 60% or more. Open 2001-238
No. 962 discloses a core and a DLC formed on the surface thereof.
Each of the medical insertion wires characterized by having a coating is disclosed.

【0003】[0003]

【発明が解決しようとする課題】しかしながら、これら
従来の技術は、弗素添加は、抗血栓性についての特性は
向上するものの、基材の使用時の変形で剥離しやすくな
ることや、機械的な耐摩耗性が低下するという問題があ
った。そのため、血液、組織液や血管、生体組織などの
人体組識はおろか使用される医薬品に対する耐付着性や
耐擬着性を有し、さらに基材のへ強固な密着性及び高い
耐摩耗性を併せ持つ医療用部材が求められていた。
However, in these conventional techniques, although the addition of fluorine improves the antithrombotic property, the addition of fluorine facilitates peeling due to deformation during use of the base material and mechanical There is a problem that wear resistance is reduced. Therefore, it has anti-adhesion and pseudo-adhesion properties to the drugs used, let alone human tissues such as blood, interstitial fluid, blood vessels, and biological tissues, and also has strong adhesion to the base material and high abrasion resistance. There has been a demand for medical parts.

【0004】[0004]

【問題を解決するための手段】上記状況に鑑み、弗素を
含有したダイヤモンド様炭素膜を被覆し、被膜表面から
深さ0.1μm以内の弗素濃度が10〜40at%とした医療用被
覆部材とすることによって、上記課題を解決した。本発
明の上記医療用被覆部材においては、被膜表面からの深
さが、0.1μmより深い領域において、弗素濃度がない
方が機械的な耐摩耗性や基材との密着性が優れるが、10
at%未満の低濃度であれば存在しても良く、基材に対し
て連続的に濃度が漸減しても良い。
[Means for Solving the Problems] In view of the above situation, a diamond-like carbon film containing fluorine is coated to provide a medical coating member having a fluorine concentration within a depth of 0.1 μm from the coating surface of 10 to 40 at%. As a result, the above problems have been solved. In the above-mentioned medical covering member of the present invention, when the depth from the surface of the coating is deeper than 0.1 μm, the absence of fluorine concentration is more excellent in mechanical abrasion resistance and adhesion to the base material.
It may be present as long as it has a low concentration of less than at%, and the concentration may be gradually reduced with respect to the base material.

【0005】また、弗素と同じ領域に存在する被膜表面
から深さ0.1μm以内の水素濃度を2〜30at%に制御する
ことによって、血液、組織液や血管、生体組織などの人
体組識はおろか使用される医薬品に対する耐付着性や耐
擬着性を維持しつつ、機械的な特性の低減を抑制できる
ため好ましい。水素濃度が2at%未満では被膜内の圧縮
残留応力が増大するために剥離しやすくなり、30at%よ
り多くては機械的な特性(硬さ、結晶性)が低下する。
そのため、被膜表面から深さ0.1μm以内の水素濃度を
2〜30at%と定めた。水素濃度は、5〜15at%がより好ま
しい。
Further, by controlling the hydrogen concentration within the depth of 0.1 μm from the surface of the film existing in the same area as that of fluorine to 2 to 30 at%, let alone the human body tissue such as blood, tissue fluid, blood vessels, and biological tissues. It is preferable because it is possible to suppress the reduction of mechanical properties while maintaining the anti-adhesion property and the anti-adhesion property to the drug. If the hydrogen concentration is less than 2 at%, the compressive residual stress in the coating increases, so that peeling easily occurs, and if it exceeds 30 at%, the mechanical properties (hardness, crystallinity) deteriorate.
Therefore, the hydrogen concentration within the depth of 0.1 μm from the coating surface was set to 2 to 30 at%. The hydrogen concentration is more preferably 5 to 15 at%.

【0006】さらに、該ダイヤモンド様炭素膜が、SP2
結合とSP3結合を有し、かつ、被膜と部材の界面から0.1
μm以内にSP3/SP2比が高い領域を有することによっ
て、基材である医療用部材との密着性が向上するため好
ましい。前記ダイヤモンド様炭素膜の膜厚が0.2〜2μ
m以下に制御することによって所望の性能がより発揮さ
れるため好ましい。
Further, the diamond-like carbon film is SP2
Bond and SP3 bond, and 0.1 from the interface between the coating and the member.
Having a region with a high SP3 / SP2 ratio within μm is preferable because it improves the adhesion to the medical member that is the base material. The diamond-like carbon film has a thickness of 0.2-2 μ
Controlling to m or less is preferable because desired performance can be further exhibited.

【0007】[0007]

【発明の実施の態様】本発明の医療用被覆材では、部材
のダイヤモンド様炭素膜表面側に弗素付加領域を有し、
基材側の弗素含有量を低く制限することによって、血
液、組織液、血管や生体組織などの人体組識はおろか使
用される医薬品に対しても優れた耐付着性や耐擬着性を
有し、さらに基材のへ強固な密着性及び高い耐摩耗性を
併せ持つ医療用被覆材が得られたものである。
BEST MODE FOR CARRYING OUT THE INVENTION The medical covering material of the present invention has a fluorine-added region on the diamond-like carbon film surface side of a member,
By limiting the fluorine content of the base material to a low level, it has excellent adhesion resistance and pseudo-adhesion resistance not only to human tissues such as blood, tissue fluid, blood vessels and living tissues but also to used pharmaceuticals. Further, a medical coating material having strong adhesion to the base material and high abrasion resistance is obtained.

【0008】本発明における医療用被覆材としては、カ
テーテル、ガイドワイヤー、ステント、ペースメーカー
リードなどの体内留置用器材や注射針、メス、(傷口保
持部品)などの直接人体に接触する部材の外に、治療時
の排出容器、バット等の容器などが挙げられるが、直接
人体に接触する部材において特に効果が顕著である。本
発明の医療用被覆材に用いる材質は、ステンレス鋼、プ
ラチナ合金、金合金、タンタル合金などの金属や、ポリ
エチレン、ポロプロピレン、ポリエチレンテレフタレー
トなどの樹脂、さらにアルミナ等のセラミック及びガラ
スなどが挙げられるが、これら実例に拘泥されるわけで
はない。これら基材は、多孔質であっては被膜の密着性
が劣るため、緻密質であることが好ましい。
[0008] The medical coating material in the present invention is a device for indwelling in a body such as a catheter, a guide wire, a stent and a pacemaker lead, and a member such as an injection needle, a scalpel, and a (wound holding component) which come into direct contact with the human body. Examples thereof include a discharge container during treatment and a container such as a vat, but the effect is particularly remarkable in a member that directly contacts the human body. Examples of the material used for the medical covering material of the present invention include metals such as stainless steel, platinum alloy, gold alloy, and tantalum alloy, resins such as polyethylene, polypropylene, polyethylene terephthalate, and ceramics such as alumina and glass. However, they are not bound by these examples. If these base materials are porous, the adhesion of the coating film is poor, so it is preferable that they are dense.

【0009】本発明の医療用被覆材におけるダイヤモン
ド様炭素膜の被覆は、物理蒸着法や化学蒸着法によって
実現できるが、複雑形状に均一に被覆できることや、弗
素の部分添加が容易であるという観点からはプラズマCV
D法が好ましい。
The coating of the diamond-like carbon film in the medical covering material of the present invention can be realized by a physical vapor deposition method or a chemical vapor deposition method. However, it is possible to uniformly coat a complicated shape and it is easy to partially add fluorine. From plasma CV
Method D is preferred.

【0010】また、ダイヤモンド様炭素膜は、水素など
のキャリアガスと炭素源となるメタン、エタン、プロパ
ン、ベンゼンなどを被覆する部材と共に真空装置内に装
入し、導入したガスをイオン化させることによって、部
材表面に形成するものである。弗素の部分付加は、弗素
を含むガス、例えば、C2F6 、CF4 などを前記キャリアガ
ス、炭素源ガスと同時に装置内に導入すうることによっ
て弗素が付加された領域を有するダイヤモンド様炭素膜
が得られる。被膜内の弗素濃度は導入する弗素含有ガス
の分圧、装置内真空度によって制御し、付加領域は、弗
素含有ガスを導入するタイミングにより制御する。
The diamond-like carbon film is charged in a vacuum apparatus together with a member for covering a carrier gas such as hydrogen and carbon sources such as methane, ethane, propane and benzene, and the introduced gas is ionized. , Is formed on the surface of the member. Partial addition of fluorine is carried out by introducing a fluorine-containing gas such as C 2 F 6 , CF 4 or the like into the apparatus at the same time as the carrier gas and carbon source gas into a diamond-like carbon having a region to which fluorine is added. A film is obtained. The fluorine concentration in the film is controlled by the partial pressure of the fluorine-containing gas to be introduced and the degree of vacuum in the apparatus, and the additional region is controlled by the timing of introducing the fluorine-containing gas.

【0011】本発明では、血液や筋肉、血管などの人体
組識はおろか使用される医薬品に対しての耐付着性や耐
擬着性は、表面から0.1μm以内の弗素濃度を10〜40at%
に制御することで所望の効果が得られることが明らかに
なった。さらに、表面から0.1μm以内の弗素付加領域
内の水素濃度を2〜30at%に制御することによって、血
液や筋肉、血管などの人体組識はおろか使用される医薬
品に対する耐付着性や耐擬着性を維持しつつ、機械的な
特性の低減を抑制するものである。具体的には、導入ガ
ス中の水素分圧を下げることによって得られる。
According to the present invention, not only human body tissues such as blood, muscles and blood vessels but also anti-adhesion and anti-adhesion properties with respect to pharmaceuticals used are 10-40 at% of fluorine concentration within 0.1 μm from the surface.
It has been clarified that the desired effect can be obtained by controlling the above. Furthermore, by controlling the hydrogen concentration in the fluoridation region within 0.1 μm from the surface to be 2 to 30 at%, the human body tissue such as blood, muscles and blood vessels, as well as the adhesion resistance and pseudo-adhesion resistance to the drug used can be prevented. While maintaining the properties, the reduction of mechanical properties is suppressed. Specifically, it can be obtained by lowering the hydrogen partial pressure in the introduced gas.

【0012】また、基材との密着性は、被膜と部材の界
面から0.1μm以内にSP3/SP2比が高い領域を有すること
によって向上することが明らかとなった。炭素被膜のと
り得る結晶構造としては種々あるが、本発明は、SP3結
合(ダイヤモンド結合)とSP2結合(グラファイト結
合)を含み、部材との界面付近のSP2量を多くすること
によって、被膜の密着性を向上させるものである。SP3
結合(ダイヤモンド結合)は、最も強固な結合であるた
め、機械的な特性は優れるものの、SP2結合がSP3
結合より多い場合は耐摩耗性が低下するものの、応力を
分散する効果が発揮されるため、部材との密着性が向上
するものである。特にSP3/SP2比が0.01〜10では、高い
密着性と優れた耐摩耗性を発揮するため好ましい。
Further, it has been revealed that the adhesion to the base material is improved by having a region having a high SP3 / SP2 ratio within 0.1 μm from the interface between the coating film and the member. Although there are various crystal structures that a carbon film can have, the present invention includes SP3 bonds (diamond bonds) and SP2 bonds (graphite bonds), and by increasing the amount of SP2 near the interface with the member, the adhesion of the film can be improved. It improves the sex. SP3
The bond (diamond bond) is the strongest bond, so the mechanical properties are excellent, but the SP2 bond is the SP3 bond.
When the amount is larger than the number of bonds, the wear resistance is reduced, but the effect of dispersing the stress is exerted, so that the adhesion with the member is improved. Particularly, when the SP3 / SP2 ratio is 0.01 to 10, it is preferable because high adhesion and excellent wear resistance are exhibited.

【0013】以上の効果は、生体内埋め込み医療器など
直接人体に接触する機器において特に効果が顕著である
が、冠動脈ステントを例に挙げてより詳細に説明する。
冠動脈ステントは冠動脈内に留置され、狭くなった血管
病変部で膨らむように設計されている。このときに、血
液や血管組識と接触するとそこに血栓が形成されてしま
う。そこで、表面にダイヤモンド様炭素膜であって、な
おかつ弗素を付加することによってこの問題は解消する
が、ステント拡張時に、当然被覆材も基材にあわせて変
形するのであるから、剥離し易くなってしまう。
The above effects are particularly remarkable in a device that directly contacts the human body such as a medical device implanted in a living body, but a coronary stent will be described in more detail as an example.
Coronary stents are placed in the coronary arteries and are designed to expand in a narrowed vascular lesion. At this time, if it comes into contact with blood or a blood vessel structure, a thrombus will be formed there. Therefore, although this problem is solved by adding a fluorine-like carbon film to the surface, and fluorine is added, naturally, when the stent is expanded, the covering material is also deformed according to the base material, so that it is easily peeled off. I will end up.

【0014】さらに、ステントを挿入するときには、カ
テーテルやガイドワイヤーなどの医療器具等と合せて使
用されることから、摩滅や傷が入ることによって確実な
手技操作が望めない。そこで、本発明のようにダイヤモ
ンド様炭素膜を被覆した部材であって、ごく表面のみに
特定濃度の弗素付加領域を設けることによって、優れた
抗血栓性や生体適合性を有し、かつ、強固な密着性及び
高い耐摩耗性を併せ持つステントが得られる。
Further, when the stent is inserted, it is used together with a medical instrument such as a catheter or a guide wire, so that a reliable manual operation cannot be expected due to abrasion or damage. Therefore, a member coated with a diamond-like carbon film as in the present invention has excellent antithrombogenicity and biocompatibility by providing a fluorine-added region of a specific concentration only on the very surface, and is strong. A stent having both excellent adhesion and high abrasion resistance can be obtained.

【0015】特にステントにおいては、時間の推移によ
るステントの変形が起り得るが、これはステントと血管
組識による応力の集中や応力の不均一な負荷によるもの
である。本発明品によっては、優れた耐凝着性を有する
ことから応力がステント全体に均一に負荷されるため変
形を抑制し、なおかつ弗素負荷領域より深部では耐変形
性に優れるSP3結合、SP2結合を有する構造であるため、
時間の経過による劣化も防止されるという効果を発揮す
る。以下に具体的に実施例を挙げて説明する。
Particularly in the case of a stent, the deformation of the stent may occur due to the passage of time, but this is due to the concentration of stress due to the stent-vessel structure and the uneven load of stress. Depending on the product of the present invention, since it has excellent adhesion resistance, stress is uniformly applied to the entire stent to suppress deformation, and SP3 bond and SP2 bond, which are excellent in deformation resistance at a depth deeper than the fluorine-loaded region, are formed. Because it has a structure,
It also has the effect of preventing deterioration over time. Specific examples will be described below.

【0016】[0016]

【実施例1】試験用の基板として、30×30×5mm形状で
SUS316製を用いた。基材は、表1に示す種々の被覆を行
い評価に用いた。成膜はプラズマCVD装置を用いた。基
材を洗浄後、成膜装置内に装入し、アルゴンイオンボン
バードによりイオン洗浄した。DLCの成膜は、水素95%、
ベンゼン5%の混合ガスを真空度1×10−3まで導入し、
弗素附加領域では、真空度が一定になるように制御しつ
つC2F6 を2%の割合で混入させた。装置内では、プラズ
マを発生させるさせるために13.56MHz、電力1kWの高
周波電力を投入し、成膜した。SP2結合とSP3結合の比
は、投入電力を200WでSP2結合の多い領域を形成
し、連続的に1kWまで電力を上昇させた。比較として
TiNを被覆形成するものは、HCD(ホローカソード)型PV
D装置でアルゴン−窒素の混合プラズマ中でTiを蒸着す
ることによりTiNを成膜した。膜厚は1.1μmとした。
[Example 1] As a substrate for testing, a 30 × 30 × 5 mm shape was used.
A product made of SUS316 was used. The substrate was subjected to various coatings shown in Table 1 and used for evaluation. A plasma CVD apparatus was used for film formation. After cleaning the substrate, the substrate was placed in a film forming apparatus and ion-cleaned by an argon ion bombardment. DLC film formation is 95% hydrogen,
Introduce a mixed gas of benzene 5% to a vacuum degree of 1 × 10 −3,
In the fluorine-added region, the C 2 F 6 Was mixed in at a rate of 2%. In the apparatus, high-frequency power of 13.56 MHz and power of 1 kW was applied to generate plasma, and a film was formed. As for the ratio of SP2 coupling to SP3 coupling, when the input power was 200 W, a region with a large amount of SP2 coupling was formed, and the power was continuously increased to 1 kW. As a comparison
What forms TiN coating is HCD (hollow cathode) type PV
A TiN film was formed by vapor depositing Ti in a D apparatus in a mixed plasma of argon-nitrogen. The film thickness was 1.1 μm.

【0017】[0017]

【表1】 [Table 1]

【0018】得られた試料は、3種の試験により評価を
行なった。 (1)試験1:血液を3cc滴下して固着させた後、粘着テ
ープで引き剥がし試験を行なった。試料に残留している
硬化血液付着量を比較した。 (2)試験2:ダイヤモンド圧子で0〜10Nまで連続的に荷
重を増加させながら皮膜上から引掻いた時に被膜が剥離
するまでの臨界荷重を比較した。 5N以下で剥離:▲、6〜10Nで剥離:○、剥離なし(微
少欠損):◎ (3)試験3:リング状(30Φ)の炭素鋼(S20C)を0.2m/
sで回転させつつ、100gの荷重で試料被覆面を血液中で
摺動させ、10min後の摩耗量を摩耗幅で比較した。 5mm以上:×、3〜5mm:△、1〜3mm:○、1mm以
下:◎
The obtained sample was evaluated by three kinds of tests. (1) Test 1: After dropping 3 cc of blood to fix it, a peeling test was conducted with an adhesive tape. The amount of hardened blood remaining in the samples was compared. (2) Test 2: While the load was continuously increased from 0 to 10 N with a diamond indenter, the critical loads until the film peeled off when scratched from above the film were compared. Peeling at 5N or less: ▲, Peeling at 6 to 10N: ○, No peeling (minor defects): ◎ (3) Test 3: 0.2m / ring of ring-shaped (30Φ) carbon steel (S20C)
While rotating at s, the sample coated surface was slid in blood with a load of 100 g, and the amount of wear after 10 minutes was compared by the wear width. 5 mm or more: ×, 3 to 5 mm: △, 1 to 3 mm: ○, 1 mm or less: ◎

【0019】[0019]

【表2】 [Table 2]

【0020】[0020]

【実施例2】試験用の基板を15φ×0.3mm形状とした、
発明品1、2、比較品3、4をラット皮下に埋植し、以
下の試験により評価した。 試験4:ラット皮下に埋植後、1週間後の急性期炎症反
応を血液学的に評価するために、血液中の成分、IL−1
β、TNF−α、C3aを表3に比較評価した。 試験5:ラット皮下に埋植後、12週間後の慢性期組識
反応を病理組識学的に評価するために、好中球、リンパ
球を表4に比較評価した。 試験6:ラット皮下に埋植時に、二つ折りにし、12週
間後の被膜剥離及び生体反応状態について表5に比較評
価した。
[Embodiment 2] The substrate for the test has a shape of 15φ × 0.3 mm,
Inventive products 1 and 2 and comparative products 3 and 4 were implanted subcutaneously in rats and evaluated by the following tests. Test 4: In order to hematologically evaluate the acute phase inflammatory reaction one week after subcutaneous implantation in the rat, a component in blood, IL-1
β, TNF-α and C3a are compared and evaluated in Table 3. Test 5: The neutrophils and lymphocytes were compared and evaluated in Table 4 in order to pathologically evaluate the chronic phase tissue reaction 12 weeks after subcutaneous implantation in the rat. Test 6: When implanted subcutaneously in a rat, it was folded in two, and 12 weeks later, the film peeling and biological reaction state were compared and evaluated in Table 5.

【0021】[0021]

【表3】 [Table 3]

【0022】[0022]

【表4】 [Table 4]

【0023】[0023]

【表5】 [Table 5]

【0024】表3、4から明らかなように、生体適合性
は優れていることがわかった。さらに、被膜の密着性及
び生体の付着性を評価した結果、表5から明らかなよう
に比較品では被膜の剥離、もしくは生体の付着(癒着)
が発生していたものの、本発明品は被膜の密着性及び生
体付着状態についても優れた性能を示した。
As is clear from Tables 3 and 4, the biocompatibility was found to be excellent. Furthermore, as a result of evaluating the adhesion of the coating and the adhesion of the living body, as is clear from Table 5, the peeling of the coating or the adhesion of the living body (adhesion) was observed in the comparative product.
However, the product of the present invention also showed excellent performance in terms of the adhesion of the coating film and the state of adherence to a living body.

【0025】[0025]

【発明の効果】本発明では、DLC被膜の含有フッ素濃
度、水素濃度、SP2/SP3比及び膜厚を適切に調整
することによって医療用部材の表面にDLC被膜を形成
するものであり、このようにして得られた表面にDLC
を被覆した医療用被覆部材は、耐付着性が優れ、耐凝着
性とともに、機械的な耐摩耗性及び密着性を併せ持って
いる。また、血液や筋肉、血管などの人体組織あるいは
医薬品に対する耐付着性や耐擬着性を維持しつつ、機械
的な特性を抑制できる。されに、本発明の医療用DLC
被覆部材は、耐摩耗性が向上し、基材に対するDLC被
膜の密着性が改善され、さらに得られた医療用器材は実
用的な、かつ、安定性が著しく優れた部材であることが
わかった。
According to the present invention, the DLC film is formed on the surface of the medical member by appropriately adjusting the contained fluorine concentration, hydrogen concentration, SP2 / SP3 ratio and film thickness of the DLC film. DLC on the surface obtained by
The medical covering member coated with is excellent in adhesion resistance and has mechanical abrasion resistance and adhesion as well as adhesion resistance. In addition, mechanical properties can be suppressed while maintaining anti-adhesion and pseudo-adhesion resistance to human tissues such as blood, muscles, blood vessels, etc. or pharmaceuticals. In addition, the medical DLC of the present invention
It was found that the coated member has improved wear resistance and improved adhesion of the DLC film to the substrate, and the medical device obtained is a practical and extremely stable member. .

───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.7 識別記号 FI テーマコート゛(参考) A61B 17/32 310 A61M 5/32 4G077 A61M 5/32 29/02 25/01 A61N 1/05 29/02 A61L 33/00 Z A61N 1/05 A61M 25/00 450B Fターム(参考) 4C053 CC02 4C060 AA00 FF03 MM24 4C066 AA09 BB01 FF05 4C081 AA01 AC06 AC08 AC09 BA02 BB04 BB08 CF002 DB07 DC03 DC06 4C167 AA28 BB05 BB06 BB13 GG26 GG41 HH02 HH30 4G077 AA03 BA03 DB18 EB01 HA20 TA03 TB02 TB07 TC02 TK10 TK13 ─────────────────────────────────────────────────── ─── Continuation of front page (51) Int.Cl. 7 Identification code FI theme code (reference) A61B 17/32 310 A61M 5/32 4G077 A61M 5/32 29/02 25/01 A61N 1/05 29/02 A61L 33/00 Z A61N 1/05 A61M 25/00 450B F-term (reference) 4C053 CC02 4C060 AA00 FF03 MM24 4C066 AA09 BB01 FF05 4C081 AA01 AC06 AC08 AC09 BA02 BB30A06 BBBB30B06B41BB05A06B30BB06B41BB05A06B30BB06A05BB30B06A05BB30A06B30BB06A06B30BB06B30H06A06B30H06AH 4G077 AA03 BA03 DB18 EB01 HA20 TA03 TB02 TB07 TC02 TK10 TK13

Claims (6)

【特許請求の範囲】[Claims] 【請求項1】 弗素を含有したダイヤモンド様炭素膜を
被覆し、被膜表面から深さ0.1μm以内の弗素濃度が10
〜20at%の弗素付加領域を有することを特徴とする医療
用被覆部材。
1. A diamond-like carbon film containing fluorine is coated so that a fluorine concentration within a depth of 0.1 μm from the coating surface is 10 or less.
A medical covering member having a fluorine added region of up to 20 at%.
【請求項2】 被膜表面から深さ0.1μm以内の水素濃
度が、2〜30at%であることを特徴とする請求項1記載
の医療用被覆部材。
2. The medical covering member according to claim 1, wherein the hydrogen concentration within the depth of 0.1 μm from the surface of the coating is 2 to 30 at%.
【請求項3】 該ダイヤモンド様炭素膜が、SP2結合とS
P3結合を有し、かつ、被膜と部材の界面から0.1μm以
内にSP3/SP2比が高い領域を有することを特徴とする請
求項1又は2記載の医療用被覆部材。
3. The diamond-like carbon film comprises SP2 bonds and S
The medical covering member according to claim 1 or 2, which has a P3 bond and has a region having a high SP3 / SP2 ratio within 0.1 µm from an interface between the film and the member.
【請求項4】 該SP3/SP2比が、0.01〜10であることを
特徴とする請求項3記載の医療用被覆部材。
4. The medical covering member according to claim 3, wherein the SP3 / SP2 ratio is 0.01 to 10.
【請求項5】 該ダイヤモンド様炭素膜が、0.2〜2μ
mであることを特徴とする請求項1〜4のいずれかに記
載の医療用被覆部材。
5. The diamond-like carbon film has a thickness of 0.2 to 2 μm.
m is a medical covering member according to any one of claims 1 to 4.
【請求項6】 カテーテル、ガイドワイヤー、ステン
ト、ペースメーカーリード、体内留置用器材、注射針、
メス、(傷口保持部品)のいずれかに用いることを特徴
とする請求項1〜5のいずれかに記載の医療用被覆部
材。
6. A catheter, a guide wire, a stent, a pacemaker lead, a device for indwelling in a body, an injection needle,
The medical covering member according to any one of claims 1 to 5, which is used for either a scalpel or (wound holding component).
JP2002122237A 2002-04-24 2002-04-24 Medical covering material Expired - Fee Related JP3714471B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2002122237A JP3714471B2 (en) 2002-04-24 2002-04-24 Medical covering material

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2002122237A JP3714471B2 (en) 2002-04-24 2002-04-24 Medical covering material

Publications (2)

Publication Number Publication Date
JP2003310744A true JP2003310744A (en) 2003-11-05
JP3714471B2 JP3714471B2 (en) 2005-11-09

Family

ID=29537907

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002122237A Expired - Fee Related JP3714471B2 (en) 2002-04-24 2002-04-24 Medical covering material

Country Status (1)

Country Link
JP (1) JP3714471B2 (en)

Cited By (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005061021A1 (en) * 2003-12-19 2005-07-07 Keio University Medical guide wire coated with carbon film
WO2006041558A3 (en) * 2004-10-08 2006-05-18 Boston Scient Scimed Inc Medical devices coated with diamond-like carbon
WO2007132570A1 (en) 2006-05-17 2007-11-22 Toyo Advanced Technologies Co., Ltd. Medical device having diamond-like thin film and method for manufacture thereof
JP2008006275A (en) * 2006-06-02 2008-01-17 Semiconductor Energy Lab Co Ltd Cardiac pacemaker device
JP2008120077A (en) * 2006-10-20 2008-05-29 Keio Gijuku Polyolefin component with improved adhesion by coating with DLC film
JP2008230880A (en) * 2007-03-19 2008-10-02 Toyo Advanced Technologies Co Ltd Method for modifying diamond-like thin film, superhydrophilic material, medical material, medical appliance and method for producing the same
JP2008539899A (en) * 2005-05-05 2008-11-20 ボストン サイエンティフィック リミテッド Medical device and method for manufacturing the medical device
JP2009527283A (en) * 2006-02-16 2009-07-30 ボストン サイエンティフィック リミテッド Medical balloon and manufacturing method thereof
WO2011021566A1 (en) * 2009-08-17 2011-02-24 川澄化学工業株式会社 Medical instrument and metal product
US8449603B2 (en) 2008-06-18 2013-05-28 Boston Scientific Scimed, Inc. Endoprosthesis coating
JP2013534854A (en) * 2010-06-28 2013-09-09 シンセス ゲゼルシャフト ミット ベシュレンクテル ハフツング Coated implants
US8574615B2 (en) 2006-03-24 2013-11-05 Boston Scientific Scimed, Inc. Medical devices having nanoporous coatings for controlled therapeutic agent delivery
US8771343B2 (en) 2006-06-29 2014-07-08 Boston Scientific Scimed, Inc. Medical devices with selective titanium oxide coatings
US8815275B2 (en) 2006-06-28 2014-08-26 Boston Scientific Scimed, Inc. Coatings for medical devices comprising a therapeutic agent and a metallic material
US8815273B2 (en) 2007-07-27 2014-08-26 Boston Scientific Scimed, Inc. Drug eluting medical devices having porous layers
US8900292B2 (en) 2007-08-03 2014-12-02 Boston Scientific Scimed, Inc. Coating for medical device having increased surface area
US8920491B2 (en) 2008-04-22 2014-12-30 Boston Scientific Scimed, Inc. Medical devices having a coating of inorganic material
US8932346B2 (en) 2008-04-24 2015-01-13 Boston Scientific Scimed, Inc. Medical devices having inorganic particle layers
JP2016016018A (en) * 2014-07-04 2016-02-01 トーヨーエイテック株式会社 Implant and manufacturing method thereof
CN105441872A (en) * 2015-04-03 2016-03-30 中奥汇成科技股份有限公司 Amorphous carbon composite coating and preparation method and application thereof
US9440003B2 (en) 2005-11-04 2016-09-13 Boston Scientific Scimed, Inc. Medical devices having particle-containing regions with diamond-like coatings
KR20190113722A (en) * 2019-09-30 2019-10-08 (주)시지바이오 Stent for medical use and method of manufacturing thereof
CN110446883A (en) * 2017-03-31 2019-11-12 株式会社理研 Sliding members and piston rings
US10823288B2 (en) 2017-03-31 2020-11-03 Kabushiki Kaisha Riken Sliding member and piston ring

Cited By (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005061021A1 (en) * 2003-12-19 2005-07-07 Keio University Medical guide wire coated with carbon film
JPWO2005061021A1 (en) * 2003-12-19 2007-12-13 学校法人慶應義塾 Medical guide wire coated with carbon film
WO2006041558A3 (en) * 2004-10-08 2006-05-18 Boston Scient Scimed Inc Medical devices coated with diamond-like carbon
JP2008515534A (en) * 2004-10-08 2008-05-15 ボストン サイエンティフィック リミテッド Medical device coated with diamond-like carbon
JP2008539899A (en) * 2005-05-05 2008-11-20 ボストン サイエンティフィック リミテッド Medical device and method for manufacturing the medical device
US9440003B2 (en) 2005-11-04 2016-09-13 Boston Scientific Scimed, Inc. Medical devices having particle-containing regions with diamond-like coatings
US9526814B2 (en) 2006-02-16 2016-12-27 Boston Scientific Scimed, Inc. Medical balloons and methods of making the same
JP2009527283A (en) * 2006-02-16 2009-07-30 ボストン サイエンティフィック リミテッド Medical balloon and manufacturing method thereof
US8574615B2 (en) 2006-03-24 2013-11-05 Boston Scientific Scimed, Inc. Medical devices having nanoporous coatings for controlled therapeutic agent delivery
US7931934B2 (en) 2006-05-17 2011-04-26 Toyo Advanced Technologies Co., Ltd. Medical device having diamond-like thin film and method for manufacturing thereof
WO2007132570A1 (en) 2006-05-17 2007-11-22 Toyo Advanced Technologies Co., Ltd. Medical device having diamond-like thin film and method for manufacture thereof
JP2008006275A (en) * 2006-06-02 2008-01-17 Semiconductor Energy Lab Co Ltd Cardiac pacemaker device
US8838244B2 (en) 2006-06-02 2014-09-16 Semiconductor Energy Laboratory Co., Ltd. Cardiac pacemaker device with circuits for monitoring residual capacity of battery
US8815275B2 (en) 2006-06-28 2014-08-26 Boston Scientific Scimed, Inc. Coatings for medical devices comprising a therapeutic agent and a metallic material
US8771343B2 (en) 2006-06-29 2014-07-08 Boston Scientific Scimed, Inc. Medical devices with selective titanium oxide coatings
JP2008120077A (en) * 2006-10-20 2008-05-29 Keio Gijuku Polyolefin component with improved adhesion by coating with DLC film
JP2008230880A (en) * 2007-03-19 2008-10-02 Toyo Advanced Technologies Co Ltd Method for modifying diamond-like thin film, superhydrophilic material, medical material, medical appliance and method for producing the same
US8815273B2 (en) 2007-07-27 2014-08-26 Boston Scientific Scimed, Inc. Drug eluting medical devices having porous layers
US8900292B2 (en) 2007-08-03 2014-12-02 Boston Scientific Scimed, Inc. Coating for medical device having increased surface area
US8920491B2 (en) 2008-04-22 2014-12-30 Boston Scientific Scimed, Inc. Medical devices having a coating of inorganic material
US8932346B2 (en) 2008-04-24 2015-01-13 Boston Scientific Scimed, Inc. Medical devices having inorganic particle layers
US8449603B2 (en) 2008-06-18 2013-05-28 Boston Scientific Scimed, Inc. Endoprosthesis coating
WO2011021566A1 (en) * 2009-08-17 2011-02-24 川澄化学工業株式会社 Medical instrument and metal product
US8900291B2 (en) 2009-08-17 2014-12-02 Kawasumi Laboratories, Inc. Medical instrument and metal product
JP5661632B2 (en) * 2009-08-17 2015-01-28 川澄化学工業株式会社 Medical instruments and metal products
US9107752B2 (en) 2010-06-28 2015-08-18 DePuy Synthes Products, Inc. Coated implant
JP2013534854A (en) * 2010-06-28 2013-09-09 シンセス ゲゼルシャフト ミット ベシュレンクテル ハフツング Coated implants
JP2016016018A (en) * 2014-07-04 2016-02-01 トーヨーエイテック株式会社 Implant and manufacturing method thereof
CN105441872A (en) * 2015-04-03 2016-03-30 中奥汇成科技股份有限公司 Amorphous carbon composite coating and preparation method and application thereof
CN110446883A (en) * 2017-03-31 2019-11-12 株式会社理研 Sliding members and piston rings
US10823288B2 (en) 2017-03-31 2020-11-03 Kabushiki Kaisha Riken Sliding member and piston ring
US10883601B2 (en) 2017-03-31 2021-01-05 Kabushiki Kaisha Riken Sliding member and piston ring
KR20190113722A (en) * 2019-09-30 2019-10-08 (주)시지바이오 Stent for medical use and method of manufacturing thereof
KR102094269B1 (en) 2019-09-30 2020-03-30 (주)시지바이오 Stent for medical use and method of manufacturing thereof

Also Published As

Publication number Publication date
JP3714471B2 (en) 2005-11-09

Similar Documents

Publication Publication Date Title
JP2003310744A (en) Medical covering members
EP2018881B1 (en) Medical device having diamond-like thin film and method for manufacture thereof
EP1795563A1 (en) Amphiphilic polymeric coating
Schmehl et al. Silicon carbide coating of nitinol stents to increase antithrombogenic properties and reduce nickel release
AU2003276523B2 (en) Method for preparing drug eluting medical devices and devices obtained therefrom
KR20190117863A (en) Method for preparation of ePTFE-based artificial vessels with enhanced hemocompatibility via selective plasma etching
JPH04501965A (en) Implantable artifacts and their manufacturing methods
JP2009153586A (en) Antithrombogenic material and method for producing the same
US20040105890A1 (en) Biocompatible injectable materials
EP4241799B1 (en) Metal material for medical device, manufacturing method for metal material for medical device, and medical device
JP4740741B2 (en) Medical guide wire coated with carbon film
EP3636294B1 (en) Method for treatment medical devices made from nickel - titanium (niti) alloys
Nakatani et al. Electrochemical Polarization Characteristics of a DLC-Coated Magnesium Alloy Stent in a Saline Solution
KR100390015B1 (en) Catalytic CVD-technique pyrelytic carbon coating method on the cardiovascular stent.
RU2809018C1 (en) Metal material for medical device, method of producing metal material for medical device, and medical device
EP3970762A1 (en) Method for manufacturing eptfe artificial blood vessels having improved hemocompatibility via selective plasma etching
Nezafati et al. Study of the Hemocompatibility of 3C–SiC and a-SiC Films Using ISO 10993-4
KR20060113904A (en) Methods for the manufacture of drug release medical devices and medical devices obtained from such methods
Colombo et al. 7. THE CARBOSTENT SIRIUS STENT
MXPA02003925A (en) Biocompatible coated implant

Legal Events

Date Code Title Description
A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20050128

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20050301

A871 Explanation of circumstances concerning accelerated examination

Free format text: JAPANESE INTERMEDIATE CODE: A871

Effective date: 20050301

A975 Report on accelerated examination

Free format text: JAPANESE INTERMEDIATE CODE: A971005

Effective date: 20050422

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20050510

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20050708

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20050809

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20050817

R150 Certificate of patent or registration of utility model

Ref document number: 3714471

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20080902

Year of fee payment: 3

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090902

Year of fee payment: 4

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090902

Year of fee payment: 4

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20100902

Year of fee payment: 5

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20100902

Year of fee payment: 5

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110902

Year of fee payment: 6

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120902

Year of fee payment: 7

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120902

Year of fee payment: 7

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130902

Year of fee payment: 8

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees